Agenda

If a Councillor has a disclosable pecuniary interest in a particular item, whether or not it is entered in the Authority’s register of interests, or any other significant interest which they consider should be declared in the public interest, they should declare the existence and, unless it is a sensitive interest as defined in the Member Code of Conduct, the nature of the interest at the commencement of the consideration of that item or as soon as it becomes apparent.

At meetings where members of the public are allowed to be in attendance and speak, any Councillor with a disclosable pecuniary interest or other significant interest may also make representations, give evidence or answer questions about the matter. The Councillor must then withdraw immediately from the meeting before the matter is discussed and any vote taken.

Where Members of the public are not allowed to be in attendance and speak, then the Councillor with a disclosable pecuniary interest should withdraw from the meeting whilst the matter is under consideration.

Councillors who have declared other significant interests should also withdraw from the meeting if they consider their continued participation in the matter would not be reasonable in the circumstances and may give rise to a perception of a conflict of interest.

Councillors are not obliged to withdraw from the meeting where a dispensation to that effect has been obtained from the Audit, Pensions

and Standards Committee.

(a)   To approve as an accurate record and the Chair to sign the minutes of the meeting of the Joint Health Overview Scrutiny Committee held on 9 March 2020;

(b)   To approve as an accurate record and the Chair to sign the deferred minutes of the Joint Health Overview and Scrutiny Committee held on 27 January 2020; and

(c)   To note the outstanding actions and matters arising.

This report sets out the latest published iteration of the North West London Collaboration of Clinical Commissioning Groups Case for Change released in August 2020. The report sets out details about the proposed merger plans and expected outcomes.

For the Committee to consider future items and on-going work programme.

Thursday, 8 October 2020